Anand Padmanabha, MD
Orthopaedic Surgery · Nashua, NHNPI 1033529409
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,440 of the $15,678 with a category attached, or 60.2%. Zimmer Biomet accounts for 73.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $5,930 and has fallen 53.7% since, to $2,746 in 2025.
Across 157 payments — averaging $99.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$12K
- Stryker$4K
- Smith+Nephew$339
- Johnson & Johnson$96
- Medtronic$42
What the payments were for
- Travel & lodging$9,44060%
- Food & beverage$6,04439%
- Education$1941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 122 | $11,558 |
| Stryker | 28 | $3,644 |
| Smith+Nephew | 5 | $339 |
| Johnson & Johnson | 1 | $96 |
| Medtronic | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$5,568
- MAKO$2,658
- Persona$1,233
- Juggerknotless Soft Anchor$743
- AEQUALIS$392
- Hips-None$327
- mymobility Platform$175
- G7$152
- ROSA-Knee$149
- ROSA$133
- Knees-None$133
- Revision$133
- ACCOLADE$131
- TRIATHLON$123
How this compares
$15,678 in reported general payments places this provider in the 80th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 69 | $605 |
| Omeprazole | 51 | $356 |
| Meloxicam | 78 | $317 |
| Tramadol Hcl | 55 | $283 |
| Pregabalin | 42 | $281 |
| Ondansetron Hcl | 58 | $272 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $217 |
| Clindamycin Hcl | 17 | $53 |
| Amoxicillin | 21 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashua
- David RichardsNashua$122K
- Christian KlareNashua$88K
- Matthew WilkeningNashua$79K
- Thomas FortneyNashua$54K
- Peter EyvazzadehNashua$19K
- Bryan BeanNashua$11K
- Andrew GarberNashua$9K
- Jason SmoakNashua$8K
- James BargerNashua$7K
- Daniel BouvierNashua$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.